SMAD3 and neoplasm: In parallel, comparing with mice treated with Smad3 wild-type NK cells, the proportion of GM-CSF producing NK in the tumor microenvironment was largely promoted in those treated with Smad3 knockout NK cells, but reversed in mice treated with GM-CSF-silenced Smad3 knockout NK (Fig. 3B).